(EXA) Exail Technologies S.A. - Ratings and Ratios
Marine Robotics, Naval Electronics, Defense Simulation
EXA EPS (Earnings per Share)
EXA Revenue
Description: EXA Exail Technologies S.A.
Exail Technologies S.A. (EXA) is a French aerospace and defense company, listed as common stock. The companys market capitalization stands at approximately €2016.11 million, indicating a significant presence in the industry.
Given the negative Return on Equity (RoE) of -12.09%, its clear that the company is currently facing challenges in generating profits from shareholders equity. This metric suggests that the companys management and operational strategies may need to be reassessed to improve profitability.
The absence of meaningful P/E and Forward P/E ratios complicates traditional valuation analyses, potentially due to negative earnings. To accurately assess the companys value, alternative metrics such as Enterprise Value to EBITDA (EV/EBITDA) or Price-to-Book (P/B) ratio may be more suitable.
As a player in the aerospace and defense sector, Exail Technologies is influenced by key economic drivers such as government defense spending, global security concerns, and the demand for advanced technologies in the aerospace industry. Key Performance Indicators (KPIs) to monitor include revenue growth, order backlog, and the success of research and development initiatives.
The stocks beta of 0.916 indicates that it is slightly less volatile than the overall market, suggesting a relatively stable investment opportunity. However, the significant difference between the 52-week high (€127.80) and low (€16.54) prices highlights the potential for considerable price swings, underscoring the need for careful risk assessment.
EXA Stock Overview
| Market Cap in USD | 2,361m |
| Sub-Industry | Aerospace & Defense |
| IPO / Inception |
EXA Stock Ratings
| Growth Rating | 93.7 |
| Fundamental | 68.0% |
| Dividend Rating | 1.0 |
| Rel. Strength | 357 |
| Analysts | - |
| Fair Price Momentum | 154.53 EUR |
| Fair Price DCF | 22.54 EUR |
EXA Dividends
Currently no dividends paidEXA Growth Ratios
| Growth Correlation 3m | 94.7% |
| Growth Correlation 12m | 93% |
| Growth Correlation 5y | 79.1% |
| CAGR 5y | 64.83% |
| CAGR/Max DD 5y | 1.86 |
| Sharpe Ratio 12m | 0.92 |
| Alpha | 527.76 |
| Beta | 0.595 |
| Volatility | 55.97% |
| Current Volume | 39k |
| Average Volume 20d | 60.8k |
| Stop Loss | 105.8 (-7%) |
| Signal | -0.18 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (-15.3m TTM) > 0 and > 6% of Revenue (6% = 39.3m TTM) |
| FCFTA 0.16 (>2.0%) and ΔFCFTA 9.31pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 9.51% (prev 15.93%; Δ -6.42pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.18 (>3.0%) and CFO 153.8m > Net Income -15.3m (YES >=105%, WARN >=100%) |
| Net Debt (298.4m) to EBITDA (60.1m) ratio: 4.96 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.25 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (17.0m) change vs 12m ago -0.31% (target <= -2.0% for YES) |
| Gross Margin 39.01% (prev 38.47%; Δ 0.53pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 79.72% (prev 55.22%; Δ 24.50pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.59 (EBITDA TTM 60.1m / Interest Expense TTM 40.9m) >= 6 (WARN >= 3) |
Altman Z'' 1.28
| (A) 0.07 = (Total Current Assets 312.7m - Total Current Liabilities 250.4m) / Total Assets 831.6m |
| (B) 0.12 = Retained Earnings (Balance) 97.5m / Total Assets 831.6m |
| (C) 0.03 = EBIT TTM 24.2m / Avg Total Assets 822.4m |
| (D) 0.20 = Book Value of Equity 127.1m / Total Liabilities 627.6m |
| Total Rating: 1.28 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 68.02
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 5.74% = 2.87 |
| 3. FCF Margin 19.96% = 4.99 |
| 4. Debt/Equity 2.64 = -0.22 |
| 5. Debt/Ebitda 5.26 = -2.50 |
| 6. ROIC - WACC 4.66% = 5.82 |
| 7. RoE -12.09% = -2.02 |
| 8. Rev. Trend 84.74% = 4.24 |
| 9. Rev. CAGR 70.08% = 2.50 |
| 10. EPS Trend data missing |
| 11. EPS CAGR 13.38% = 1.34 |
What is the price of EXA shares?
Over the past week, the price has changed by -3.72%, over one month by +17.56%, over three months by +121.83% and over the past year by +558.56%.
Is Exail Technologies S.A. a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EXA is around 154.53 EUR . This means that EXA is currently undervalued and has a potential upside of +35.79% (Margin of Safety).
Is EXA a buy, sell or hold?
What are the forecasts/targets for the EXA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 123.8 | 8.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 171.9 | 51% |
EXA Fundamental Data Overview
Market Cap EUR = 2.02b (2.02b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 53.1m EUR (Cash And Short Term Investments, last quarter)
P/S = 5.0711
P/B = 16.8114
Beta = 0.916
Revenue TTM = 655.7m EUR
EBIT TTM = 24.2m EUR
EBITDA TTM = 60.1m EUR
Long Term Debt = 269.2m EUR (from longTermDebt, last quarter)
Short Term Debt = 47.1m EUR (from shortTermDebt, last quarter)
Debt = 316.3m EUR (Calculated: Short Term 47.1m + Long Term 269.2m)
Net Debt = 298.4m EUR (from netDebt column, last quarter)
Enterprise Value = 2.28b EUR (2.02b + Debt 316.3m - CCE 53.1m)
Interest Coverage Ratio = 0.59 (Ebit TTM 24.2m / Interest Expense TTM 40.9m)
FCF Yield = 5.74% (FCF TTM 130.8m / Enterprise Value 2.28b)
FCF Margin = 19.96% (FCF TTM 130.8m / Revenue TTM 655.7m)
Net Margin = -2.34% (Net Income TTM -15.3m / Revenue TTM 655.7m)
Gross Margin = 39.01% ((Revenue TTM 655.7m - Cost of Revenue TTM 399.9m) / Revenue TTM)
Tobins Q-Ratio = 17.93 (Enterprise Value 2.28b / Book Value Of Equity 127.1m)
Interest Expense / Debt = 4.66% (Interest Expense 14.7m / Debt 316.3m)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.25 (Total Current Assets 312.7m / Total Current Liabilities 250.4m)
Debt / Equity = 2.64 (Debt 316.3m / last Quarter total Stockholder Equity 119.9m)
Debt / EBITDA = 5.26 (Net Debt 298.4m / EBITDA 60.1m)
Debt / FCF = 2.42 (Debt 316.3m / FCF TTM 130.8m)
Total Stockholder Equity = 126.6m (last 4 quarters mean)
RoA = -1.84% (Net Income -15.3m, Total Assets 831.6m )
RoE = -12.09% (Net Income TTM -15.3m / Total Stockholder Equity 126.6m)
RoCE = 6.11% (Ebit 24.2m / (Equity 126.6m + L.T.Debt 269.2m))
RoIC = 4.66% (Ebit 24.2m / (Assets 831.6m - Current Assets 312.7m))
WACC = unknown (E(2.02b)/V(2.33b) * Re(8.21%)) + (D(316.3m)/V(2.33b) * Rd(4.66%) * (1-Tc(none)))
Shares Correlation 5-Years: 0.0 | Cagr: 4.69%
Discount Rate = 8.21% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 65.92% ; FCFE base≈99.4m ; Y1≈56.1m ; Y5≈18.9m
Fair Price DCF = 22.54 (DCF Value 382.4m / Shares Outstanding 17.0m; 5y FCF grow -50.0% → 3.0% )
Revenue Correlation: 84.74 | Revenue CAGR: 70.08%
Revenue Growth Correlation: -60.79%
EPS Correlation: N/A | EPS CAGR: 13.38%
EPS Growth Correlation: 26.73%